Crossmark

Response To “Superior Cerebrovascular Outcomes with Tirzepatide Versus Semaglutide: A Call for Cautious Interpretation of Observational Data”

Published Online: 2025-11-29

Authors

Hussein, Mohammad H.

Toraih, Eman A. https://orcid.org/0000-0001-9267-3787
License Information

Text and Data Mining valid from 2025-11-29

Version of Record valid from 2025-11-29
More Information

Article History

Accepted: 13 November 2025

First Online: 29 November 2025

Declarations

:

: Not applicable for correspondence.

: The authors declare no competing interests.

Free to read: This content has been made available to all.

Document is current